Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125427534 | 12542753 | 4 | F | 2014 | 20160810 | 20160709 | 20160818 | EXP | GB-AMGEN-GBRSP2016087653 | AMGEN | 62.00 | YR | A | F | Y | 49.00000 | KG | 20160818 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125427534 | 12542753 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Intravenous (not otherwise specified) | 150 MCG, QWK | U | 103951 | 150 | UG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125427534 | 12542753 | 1 | Nephrogenic anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125427534 | 12542753 | HO |
| 125427534 | 12542753 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125427534 | 12542753 | Anaemia | |
| 125427534 | 12542753 | Drug ineffective | |
| 125427534 | 12542753 | Haemodialysis | |
| 125427534 | 12542753 | Haemoglobin decreased | |
| 125427534 | 12542753 | Kidney transplant rejection | |
| 125427534 | 12542753 | Reticulocyte count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125427534 | 12542753 | 1 | 201005 | 0 |